Safety of vaccine adjuvants: Focus on autoimmunity. Issue 13 (24th March 2015)

• Record Type: Journal Article
• Authors: van der Laan, Jan Willem; Gould, Sarah; Tanir, Jennifer Y.; ILSI HESI Vaccines and Adjuvants Safety Project Committee
• Is Part Of: Vaccine. Volume 33:Issue 13(2015)
• Page Start: 1507
• Page End: 1514
• Publication Date: 2015-03-24
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.01.073
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Industrial, academic, and governmental experts studied vaccine adjuvants safety.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Evidence of signals for autoimmune disorders associated with adjuvants was reviewed.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Existing adjuvants (used in marketed vaccines) and novel adjuvants were included.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">The focus was on oil-in-water emulsion and toll-like receptor agonist adjuvants.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">No compelling evidence was found associating adjuvants and autoimmunity in humans.</p> </list-item> </list> </p> </sec> </abstract>